Hospitals can be dangerous places. While healthcare-associated infections (HAIs) have steadily decreased in the United States, the proportion of drug-resistant cases could be increasing. They are in the case of pediatric Pseudomonas aeruginosa infections.
A study published today in the Journal of the Pediatric Infectious Diseases Society, by CDDEP researchers and co-authors, finds that in just over a decade, multidrug-resistant cases of P. aeruginosa, a common healthcare-associated infection, have increased from 15.4 percent to 26 percent of all P. aeruginosa cases in U.S. pediatric settings. Over the same period, the proportion of carbapenem resistant (CR) P. aeruginosa increased from 9.4 percent to 20 percent. That’s a 4 percent increase in each type of resistance every year.
The Centers for Disease Control and Prevention (CDC) estimates that 51,000 healthcare-associated P. aeruginosa infections occur in adults and children each year, of which 13 percent are multidrug-resistant and responsible for 400 deaths annually.
Healthcare-associated infections are not a new phenomenon. However, as they become increasingly resistant to antibiotics, they will continue to raise hospital and societal costs, and pose an even greater threat to patient safety.
Read the study in the Journal of the Pediatric Infectious Diseases Society: http://jpids.oxfordjournals.org/lookup/doi/10.1093/jpids/piw064
Graphic from ResistanceMap
ResistanceMap is a web-based collection of data visualization tools developed by CDDEP, featuring antibiotic consumption data from 75 countries and antibiotic resistance data from 49 countries.
Image via Denise Chan (CC BY-SA 2.0)